Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Regenseal
Therapeutic Area : Immunology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis
Details : Regenseal is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fasciitis, Plantar.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 02, 2015
Lead Product(s) : Regenseal
Therapeutic Area : Immunology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Autologous Cultured Chondrocyte
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Autologous Cultured Chondrocyte is a Cell and Gene Therapy drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Articular Cartilage Disorder.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
September 01, 2015
Lead Product(s) : Autologous Cultured Chondrocyte
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
